Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Intervalo de año de publicación
1.
Bioorg Med Chem Lett ; 23(6): 1803-7, 2013 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-23403080

RESUMEN

Eighteen new hydrazino-1,3-thiazole derivatives were evaluated against 8 strains of multi-resistant Candida spp. Introduction of an indolyl moiety linked to the hydrazone function enhanced the in vitro anti-Candida activity, with an activity spectrum towards Candida albicans strains. Introduction of a (S)-2-aminoethyl chain on the thiazole nucleus largely enhanced the in vitro antifungal activity, with a selectivity oriented towards non-C. albicans species.


Asunto(s)
Antifúngicos/síntesis química , Tiazoles/química , Animales , Antifúngicos/farmacología , Antifúngicos/toxicidad , Candida/efectos de los fármacos , Candida albicans/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Farmacorresistencia Fúngica/efectos de los fármacos , Ratones , Pruebas de Sensibilidad Microbiana , Células 3T3 NIH , Relación Estructura-Actividad , Tiazoles/farmacología , Tiazoles/toxicidad
3.
Bioorg Med Chem Lett ; 19(5): 1386-91, 2009 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-19181521

RESUMEN

The 1,5-benzothiazepine-4-one scaffold was earlier shown to provide efficient protease inhibitors. In this contribution, we describe its use in the design of factor VIIa/tissue factor inhibitors. A series containing a scaffold non-substituted on its aryl part led to compound 20 with an IC(50) of 2.16 microM. Following molecular modelling studies of this compound, a second series was prepared, which necessitated the synthesis of protected 7- or 8-substituted 1,5-benzothiazepine-4-one derivatives.


Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Diseño de Fármacos , Factor VIIa/antagonistas & inhibidores , Tiazepinas/síntesis química , Tromboplastina/antagonistas & inhibidores , Evaluación Preclínica de Medicamentos/métodos , Factor VIIa/metabolismo , Humanos , Tiazepinas/administración & dosificación , Tiazepinas/farmacología , Tromboplastina/metabolismo
4.
J Org Chem ; 72(7): 2662-5, 2007 Mar 30.
Artículo en Inglés | MEDLINE | ID: mdl-17323999

RESUMEN

A series of 10 optically pure 3,4-dihydro-1H-thieno[3,2-e][1,4]diazepine-2,5-dione derivatives has been synthesized in 41-75% yields on treatment of 1H-thieno[3,2-d][1,3]oxazine-2,4-dione with different natural alpha-amino acids.


Asunto(s)
Azepinas/síntesis química , Oxazinas/síntesis química , Amidas/química , Anhídridos/química , Azepinas/química , Estructura Molecular , Oxazinas/química
5.
J Org Chem ; 68(19): 7316-21, 2003 Sep 19.
Artículo en Inglés | MEDLINE | ID: mdl-12968881

RESUMEN

Various 3-substituted chiral 1,2,4-oxadiazole-containing Fmoc-beta(3)- and -alpha-amino acids were synthesized from Fmoc-(l or d)-Asp(OtBu)-OH and Fmoc-l-Asp-OtBu, respectively, in three steps (i.e., condensation of an aspartyl derivative with differentially substituted amidoximes, formation of the 1,2,4-oxadiazole, and cleavage of the tert-butyl ester). These compounds represent new series of nonnatural amino acids, which could be used in combinatorial synthesis. A simple protocol has been developed to generate the 1,2,4-oxadiazole ring. Indeed, common methods resulted in cleavage of the Fmoc group or required long reaction times. We found that sodium acetate in refluxing ethanol/water (86 degrees C) was a convenient and efficient catalyst to promote conversion of Fmoc-amino acyl amidoximes to 1,2,4-oxadiazoles, and this procedure proved to be compatible with Fmoc protection. It is shown that these compounds can be prepared without significant loss of enantiomerical purity. Furthermore, the alkaline conditions used to cleave the Fmoc protecting group from these compounds did not induce epimerization of their chiral center.


Asunto(s)
Aminoácidos/síntesis química , Oxadiazoles/síntesis química , Ácido Aspártico/química , Técnicas Químicas Combinatorias , Diseño de Fármacos
6.
J Biol Chem ; 278(28): 25859-66, 2003 Jul 11.
Artículo en Inglés | MEDLINE | ID: mdl-12736275

RESUMEN

We have set up stably transfected HEK293 cells overexpressing the beta-secretases BACE1 and BACE2 either alone or in combination with wild-type beta-amyloid precursor protein (betaAPP). The characterization of the betaAPP-derived catabolites indicates that cells expressing BACEs produce less genuine Abeta1- 40/42 but higher amounts of secreted sAPPbeta and N-terminal-truncated Abeta species. This was accompanied by a concomitant modulation of the C-terminal counterpart products C89 and C79 for BACE1 and BACE2, respectively. These cells were used to set up a novel BACE assay based on two quenched fluorimetric substrates mimicking the wild-type (JMV2235) and Swedish-mutated (JMV2236) betaAPP sequences targeted by BACE activities. We show that BACEs activities are enhanced by the Swedish mutation and maximal at pH 4.5. The specificity of this double assay for genuine beta-secretase activity was demonstrated by means of cathepsin D, a "false positive" BACE candidate. Thus, cathepsin D was unable to cleave preferentially the JMV2236-mutated substrate. The selectivity of the assay was also emphasized by the lack of JMV cleavage triggered by other "secretases" candidates such as ADAM10 (A disintegrin and metalloprotease 10), tumor necrosis alpha-converting enzyme, and presenilins 1 and 2. Finally, the assay was used to screen for putative in vitro BACE inhibitors. We identified a series of statine-derived sequences that dose-dependently inhibited BACE1 and BACE2 activities with IC50 in the micromolar range, some of which displaying selectivity for either BACE1 or BACE2.


Asunto(s)
Precursor de Proteína beta-Amiloide/metabolismo , Ácido Aspártico Endopeptidasas/biosíntesis , Espectrometría de Fluorescencia/métodos , Secretasas de la Proteína Precursora del Amiloide , Precursor de Proteína beta-Amiloide/genética , Catepsina D/metabolismo , Línea Celular , Relación Dosis-Respuesta a Droga , Endopeptidasas , Inhibidores Enzimáticos/farmacología , Humanos , Concentración de Iones de Hidrógeno , Hidrólisis , Concentración 50 Inhibidora , Cinética , Modelos Químicos , Mutación , Péptidos/química , Unión Proteica , Estructura Terciaria de Proteína , Factores de Tiempo , Transfección
7.
Rev. farm. bioquim. Univ. Säo Paulo ; 34(2): 77-83, jul.-dez. 1998. ilus, tab
Artículo en Portugués | LILACS | ID: lil-235220

RESUMEN

As tiossemicarbazonas constituem classe de compostos que têm apresentado amplo espectro de ação, englobando atividades antibeoplásica, antiinflamatória, tuberculostática e antiviral, inclusive anti-HIV. Diante da potencial atividade antiviral das tiossemicarbazonas, planejamos sintetizar nova série de compostos a partir da tiossemicarbazida e fenoxiacetaldeídos diversamente substituídos. Os produtos obtidos tiveram sua estrutura química comprovada por meio de métodos espectroscópicos no infravermelho e ressonância magnética nuclear de hidrogênio e microanálise. Cinco compostos foram testados visando encontrar possível atividade antiviral. Nos ensaios utilizaram-se culturas de células contínuas VERO e L929 infectadas pelo vírus herpes humano tipo I, da vaccínia, poliomielítico tipo I e da estomatite vesiculosa...


Asunto(s)
Antivirales , Fenoxiacetatos/síntesis química , Tiosemicarbazonas/síntesis química , Técnicas de Cultivo de Célula , Espectroscopía de Resonancia Magnética/métodos
8.
Rev. ciênc. farm ; 19(1): 49-66, 1998. ilus, tab, graf
Artículo en Portugués | LILACS | ID: lil-229470

RESUMEN

Este trabalho descreve a síntese e avaliaçäo estrutural de nove tiossemicarbazonas, obtidas pela condensaçäo de ariltioacetaldeídos e artiopropanonas substituídas com cloridrato de tiossemicarbazida. Estes novos compostos foram testados in vitro pelo fitoteste Lepidium sativum. Todos eles apresentaram atividade inibidora do crescimento celular (pI50) superior àquela de 5-fluoruacila, composto anticancerígeno, utilizado como referência.


Asunto(s)
Animales , Antineoplásicos/síntesis química , Inhibidores de Crecimiento , Técnicas In Vitro , Tiosemicarbazonas/síntesis química , Aldehídos/farmacología , Aldehídos/síntesis química , Espectroscopía de Resonancia Magnética , Semicarbazonas/síntesis química , Semicarbazonas/farmacología , Espectrofotometría Infrarroja , Relación Estructura-Actividad , Tiosemicarbazonas/química , Tiosemicarbazonas/farmacología
9.
Rev. farm. bioquim. Univ. Säo Paulo ; 28(2): 114-21, jul.-dez. 1992. ilus, tab
Artículo en Portugués | LILACS | ID: lil-119017

RESUMEN

Varias guanil-hidrazonas derivadas de ariltioalquilidenos tiveram suas atividades antibacterianas testadas frente as seguintes bacterias: Escherichia coli, Staphylococcus aureus e Pseudomonas aeruginosa. Foram determinadas as concentracoes inibitorias minimas (CIM) e alguns compostos apresentaram moderada atividade sobre as duas primeiras bacterias e fraca atividade frente a P. aeruginosa


Asunto(s)
Escherichia coli/efectos de los fármacos , Hidrazonas/farmacología , Pseudomonas aeruginosa/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Química Farmacéutica , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...